BMX

2-acetamido-2-deoxy-6-O-phosphono-alpha-D-mannopyranose

Created:	2011-05-10
Last modified:	2020-07-17

Find Related PDB Entry
5 entries where BMX is found as a standalone ligand1 entries where BMX is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	5
Bond Count	35
Aromatic Bond Count	0

2D diagram of BMX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-acetamido-2-deoxy-6-O-phosphono-alpha-D-mannopyranose
Synonyms	2-(ACETYLAMINO)-2-DEOXY-6-O-PHOSPHONO-ALPHA-D-MANNOPYRANOSE; N-acetyl-6-O-phosphono-alpha-D-mannosamine; 2-acetamido-2-deoxy-6-O-phosphono-alpha-D-mannose; 2-acetamido-2-deoxy-6-O-phosphono-D-mannose; 2-acetamido-2-deoxy-6-O-phosphono-mannose
Systematic Name (OpenEye OEToolkits)	[(2R,3S,4R,5S,6S)-5-acetamido-3,4,6-tris(oxidanyl)oxan-2-yl]methyl dihydrogen phosphate
Formula	C₈ H₁₆ N O₉ P
Molecular Weight	301.188
Type	D-SACCHARIDE, ALPHA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=P(O)(O)OCC1OC(O)C(NC(=O)C)C(O)C1O
SMILES	CACTVS	3.370	CC(=O)N[CH]1[CH](O)O[CH](CO[P](O)(O)=O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.7.2	CC(=O)NC1C(C(C(OC1O)COP(=O)(O)O)O)O
Canonical SMILES	CACTVS	3.370	CC(=O)N[C@@H]1[C@@H](O)O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.7.2	CC(=O)N[C@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)COP(=O)(O)O)O)O
InChI	InChI	1.03	InChI=1S/C8H16NO9P/c1-3(10)9-5-7(12)6(11)4(18-8(5)13)2-17-19(14,15)16/h4-8,11-13H,2H2,1H3,(H,9,10)(H2,14,15,16)/t4-,5+,6-,7-,8+/m1/s1
InChIKey	InChI	1.03	BRGMHAYQAZFZDJ-UOLFYFMNSA-N

Related Resource References

Resource Name	Reference
PubChem	440273
ChEBI	CHEBI:62165

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.